Back to Hood River Capital Management LLC Hood River Capital Management LLC

BBIOBBIO
4 quarters

Position history for Hood River Capital Management LLCHood River Capital Management LLC's holdings in BRIDGEBIO PHARMA INC

Yes. Hood River Capital Management holds 1,347,535 shares of BBIO (Bridgebio Pharma), worth $100.4M, as of its Q2 2026 13F filing. It increased the position by 82,455 shares (+6.5%) from Q1 2026. Hood River Capital Management has held BBIO since Q3 2025, across 4 quarterly 13F filings. BBIO is 0.7% of Hood River Capital Management's reported 13F portfolio.

Current Value

$100.4M

Current Shares

1.3M

Total Value Change

+$35.8M

Total Shares Change

+103,990

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.3M
+6.5%
$100.4M0.7%$74.48
45
2026-Q1
Increased
1.3M
+0.8%
$93.9M0.9%$74.26
42
2025-Q4
Increased
1.3M
+0.9%
$96M1.1%$76.49
47
2025-Q3
New
1.2M
-
$64.6M0.8%$51.94
58

Other major holders of BBIO: VIKING GLOBAL INVESTORS LP, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used